Wajd Life Trading Co.
9647XSAUSaudi Exchange·Healthcare
SAR 4.64
0.00%(0.00)
Closed
Data as of Aug 6, 2026Data as of 6 Aug 2026
Open
SAR 4.64
High
SAR 4.64
Low
SAR 4.64
Volume
7
52W High
SAR 7.00
52W Low
SAR 4.64
1W
0.00%
1M
-5.31%
3M
-7.39%
6M
-16.40%
YTD
-17.88%
1Y
-15.79%
Mīzān Analysis
18/60
Weak overall profile at current prices
Low LiquidityData as of 13 Aug 2026 — may be outdated
9647Sector
Market Cap
58.0M SAR
P/E
—
Revenue Growth
55.0%
Div Yield
—
Rewards
No standout positive signals at current scores.
Risk Analysis
No significant risk flags at current scores.
Scores computed 13 Aug 2026
Fundamentals
Market Cap
P/E Ratio
P/B Ratio
EPS
EPS Growth
Revenue
Revenue Growth
Net Income
Profit Margin
Debt / Assets
Dividend Yield
Dividend Per Share
Shares Outstanding
Reporting Period: 2025-12-31Data as of Aug 6, 2026
Mizān Summary
News
Sector News10Industry & macro context
Oman boosts pharma investment via offtake, price deals
Oman Observer· 2 days agoNeutralEconomy
36Kr Global Middle East: Middle East & Africa Biotech Market CAGR Exceeds 10% – Qatar Accelerates Biotech Industry Layout
36 Kr· 6 days agoPositiveEconomy
Bahrain Chamber Strengthens Healthcare Collaboration
News of Bahrain· 11 days agoNeutralEconomy
Novo Nordisk appoints new Gulf chief amid regional growth
Gulf Business· 23 days agoNeutralEconomy
New labs aim to enable Abu Dhabi’s biotech ambitions
AGBI· 30 days ago
Qatar reaffirms efforts to strengthen IP system at WIPO meeting in Geneva
Qatar Tribune· about 1 month agoEconomy
Oman offers RO 16 million healthcare projects
Oman Observer· about 1 month agoEconomy
Oman Launches RO 16 Million Healthcare Projects: What This Means for Investors and Entrepreneurs
omanet.om· about 1 month agoEconomy
Oman pharmaceutical market to hit $1.24 billion
Oman Observer· about 1 month agoNeutralEconomy
Oman's Pharmaceutical Market to Reach $1.24 Billion: What This Growth Means for Investors and Entrepreneurs
omanet.om· about 1 month agoNeutralEconomy
